var data={"title":"Evaluation of adults with cutaneous lesions of vasculitis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Evaluation of adults with cutaneous lesions of vasculitis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/contributors\" class=\"contributor contributor_credentials\">Nicole Fett, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/contributors\" class=\"contributor contributor_credentials\">Jeffrey Callen, MD, FACP, FAAD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/contributors\" class=\"contributor contributor_credentials\">Abena O Ofori, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 01, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H16171969\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cutaneous vasculitis can occur as a consequence of multiple disorders and is characterized by a wide variety of clinical findings. Because other diseases may present with similar clinical features, histopathologic examination is essential for confirming the diagnosis. </p><p>Patients with skin vasculitis are at risk for vasculitis involving other organs. In addition, the cause of cutaneous vasculitis is not always immediately clear. The performance of a thorough patient history and physical examination will guide the selection of the appropriate laboratory and radiologic studies for patient evaluation.</p><p>The clinical, histopathologic, and laboratory assessment of adults with cutaneous lesions suspicious for vasculitis will be reviewed here. The assessment of childhood vasculitis, the assessment of patients with retiform purpura, and detailed information on specific types of cutaneous vasculitis are discussed elsewhere. (See <a href=\"topic.htm?path=vasculitis-in-children-evaluation\" class=\"medical medical_review\">&quot;Vasculitis in children: Evaluation&quot;</a> and <a href=\"topic.htm?path=approach-to-the-patient-with-retiform-angulated-purpura\" class=\"medical medical_review\">&quot;Approach to the patient with retiform (angulated) purpura&quot;</a> and <a href=\"topic.htm?path=overview-of-and-approach-to-the-vasculitides-in-adults\" class=\"medical medical_review\">&quot;Overview of and approach to the vasculitides in adults&quot;</a> and <a href=\"topic.htm?path=management-of-adults-with-idiopathic-cutaneous-small-vessel-vasculitis\" class=\"medical medical_review\">&quot;Management of adults with idiopathic cutaneous small vessel vasculitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1117785\"><span class=\"h1\">ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cutaneous vasculitis results from inflammation of the small or medium-sized blood vessels in the skin. Small blood vessels are capillaries, post-capillary venules, and nonmuscular arterioles in the superficial and mid-dermis (&lt;50 micrometers). Medium-sized vessels consist of 50 to 150 micrometer vessels with muscular walls in the deep dermis and subcutis [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/1-5\" class=\"abstract_t\">1-5</a>]. </p><p>Cutaneous vasculitis occurs in a wide variety of clinical settings (<a href=\"image.htm?imageKey=DERM%2F59048\" class=\"graphic graphic_table graphicRef59048 \">table 1</a>). Examples of vasculitic disorders (vasculitides) that can present with cutaneous lesions include [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/6\" class=\"abstract_t\">6</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Secondary vasculitis</strong> (vasculitis related to bacterial or viral infections, medications, malignancy, or connective tissue diseases and other inflammatory disorders) &ndash; small vessels or small and medium vessels (see <a href=\"topic.htm?path=overview-of-cutaneous-small-vessel-vasculitis\" class=\"medical medical_review\">&quot;Overview of cutaneous small vessel vasculitis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Immunoglobulin A vasculitis (Henoch-Sch&ouml;nlein purpura) </strong>&ndash;<strong> </strong>small vessels (see <a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Clinical manifestations and diagnosis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Urticarial vasculitis</strong> &ndash; small vessels (see <a href=\"topic.htm?path=urticarial-vasculitis\" class=\"medical medical_review\">&quot;Urticarial vasculitis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cryoglobulinemic vasculitis</strong> &ndash; small and medium vessels (see <a href=\"topic.htm?path=overview-of-cryoglobulins-and-cryoglobulinemia\" class=\"medical medical_review\">&quot;Overview of cryoglobulins and cryoglobulinemia&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Microscopic polyangiitis</strong> &ndash; small and medium vessels (see <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-granulomatosis-with-polyangiitis-and-microscopic-polyangiitis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of granulomatosis with polyangiitis and microscopic polyangiitis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)</strong> &ndash; small and medium vessels (see <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Granulomatosis with polyangiitis (Wegener's granulomatosis)</strong> &ndash;<strong> </strong>small and medium vessels (see <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-granulomatosis-with-polyangiitis-and-microscopic-polyangiitis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of granulomatosis with polyangiitis and microscopic polyangiitis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Polyarteritis nodosa</strong> &ndash; medium vessels (see <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-polyarteritis-nodosa-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of polyarteritis nodosa in adults&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Nodular vasculitis</strong> &ndash; medium vessels (see <a href=\"topic.htm?path=panniculitis-recognition-and-diagnosis#H4122269\" class=\"medical medical_review\">&quot;Panniculitis: Recognition and diagnosis&quot;, section on 'Inflammatory disorders'</a>)</p><p/><p>It is estimated that infections, medications, connective tissue diseases, and malignancy account for 23, 20, 12, and 4 percent of cases of cutaneous vasculitis, respectively [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/7\" class=\"abstract_t\">7</a>]. In contrast, the primary systemic vasculitides (granulomatosis with polyangiitis, polyarteritis nodosa, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis) are even more uncommon causes of cutaneous vasculitis. Taken together, they account for only 4 percent of cases. The cause of vasculitis is unidentifiable in 3 to 72 percent of patients [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/7\" class=\"abstract_t\">7</a>]. (See <a href=\"topic.htm?path=management-of-adults-with-idiopathic-cutaneous-small-vessel-vasculitis\" class=\"medical medical_review\">&quot;Management of adults with idiopathic cutaneous small vessel vasculitis&quot;</a>.)</p><p>Erythema elevatum diutinum is a rare form of small vessel vasculitis that presents with red-brown or violaceous papules and nodules over the dorsal hands or extensor surfaces of the extremities (<a href=\"image.htm?imageKey=DERM%2F57008%7EDERM%2F67776\" class=\"graphic graphic_picture graphicRef57008 graphicRef67776 \">picture 1A-B</a>). Vasculitis is limited to the skin in patients with this disease.</p><p>Small vessel cutaneous vasculitis may also occur following the use of cocaine adulterated with levamisole, a veterinary anthelminthic that is known to have immunomodulatory properties [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/8-11\" class=\"abstract_t\">8-11</a>]. Patients often present with tender purpura on the ears and necrotic, retiform purpura on the trunk or extremities (<a href=\"image.htm?imageKey=DERM%2F74436%7EDERM%2F77067%7EDERM%2F55590\" class=\"graphic graphic_picture graphicRef74436 graphicRef77067 graphicRef55590 \">picture 2A-C</a>). (See <a href=\"#H810822\" class=\"local\">'Evaluation for vasculitis due to levamisole-contaminated cocaine'</a> below.)</p><p class=\"headingAnchor\" id=\"H606309\"><span class=\"h1\">TERMINOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Common terms utilized to describe subsets of cutaneous vasculitis include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Small vessel cutaneous vasculitis </strong>&ndash; This term encompasses all forms of vasculitis characterized by involvement of small blood vessels in the skin, including neutrophilic, lymphocytic, and granulomatous vasculitides.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cutaneous leukocytoclastic vasculitis </strong>&ndash; &quot;Leukocytoclastic vasculitis&quot; is a pathologic term that describes the microscopic findings of a neutrophilic small vessel vasculitis (see <a href=\"#H16171991\" class=\"local\">'Biopsy'</a> below). &quot;Cutaneous leukocytoclastic vasculitis&quot; is a clinical term that describes this type of vasculitis when it is limited to the skin, such as is common in secondary vasculitides (see <a href=\"#H1117785\" class=\"local\">'Etiology'</a> above). Alternative terms include <strong>cutaneous leukocytoclastic angiitis</strong> and <strong>cutaneous necrotizing venulitis</strong>.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hypersensitivity vasculitis </strong>&ndash; &quot;Hypersensitivity vasculitis&quot; refers to cutaneous vasculitis that is secondary to a known or suspected antigen. Use of this term has fallen out of favor with some authors due to the common misclassification of these cases [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/7\" class=\"abstract_t\">7</a>]. (See <a href=\"topic.htm?path=overview-of-cutaneous-small-vessel-vasculitis\" class=\"medical medical_review\">&quot;Overview of cutaneous small vessel vasculitis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H16171977\"><span class=\"h1\">CUTANEOUS FINDINGS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The morphology of cutaneous lesions of vasculitis is variable and usually correlates with the pathologic process that is occurring in the skin [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2-4\" class=\"abstract_t\">2-4</a>]. Macular and papular lesions are characteristically nonblanchable due to the presence of extravasated erythrocytes in the dermis, which occurs as a result of damaged vessel walls. </p><p>Diascopy (the application of pressure to a skin lesion with a glass slide) is a helpful technique for identifying nonblanchable lesions. Blanchable erythematous skin lesions are common in nonvasculitic inflammatory dermatoses.</p><p class=\"headingAnchor\" id=\"H606666\"><span class=\"h2\">Common features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Common clinical features of cutaneous vasculitis include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Petechiae </strong>&ndash; Petechiae are nonblanchable and nonpalpable pinpoint macules (less than a few millimeters in diameter) that result from capillary inflammation and red blood cell extravasation (<a href=\"image.htm?imageKey=DERM%2F58626\" class=\"graphic graphic_picture graphicRef58626 \">picture 3</a>) [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2\" class=\"abstract_t\">2</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Palpable purpura </strong>&ndash; Palpable purpura are a common manifestation of small vessel vasculitis. Brisk inflammation of venules and arterioles initially manifests as infiltrated erythematous papules and plaques. These progress to raised, nonblanchable (purpuric) lesions as damage to vessel walls increases (<a href=\"image.htm?imageKey=DERM%2F79783%7EDERM%2F70300\" class=\"graphic graphic_picture graphicRef79783 graphicRef70300 \">picture 4A-B</a>) [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2\" class=\"abstract_t\">2</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hemorrhagic bullae </strong>&ndash; Small vessel involvement throughout the dermis can result in necrosis of overlying tissue and extravasation of red blood cells (<a href=\"image.htm?imageKey=DERM%2F57440\" class=\"graphic graphic_picture graphicRef57440 \">picture 5</a>) [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2\" class=\"abstract_t\">2</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Subcutaneous nodules </strong>&ndash; Intense inflammation of medium-sized vessels (vessels with muscular walls in the deep dermis and subcutis) can lead to the formation of nodular lesions (<a href=\"image.htm?imageKey=DERM%2F75828\" class=\"graphic graphic_picture graphicRef75828 \">picture 6</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Ulceration or digital necrosis </strong>&ndash; Ulceration and tissue necrosis occur when vasculitis results in reduced vascular perfusion in the skin (<a href=\"image.htm?imageKey=DERM%2F75391%7EDERM%2F58586\" class=\"graphic graphic_picture graphicRef75391 graphicRef58586 \">picture 7A-B</a>) [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2\" class=\"abstract_t\">2</a>]. Superficial ulcers can occur in patients with small vessel vasculitis; deep ulcers are usually the result of medium vessel disease [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/12\" class=\"abstract_t\">12</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Livedo reticularis and livedo racemosa </strong>&ndash; Livedo reticularis presents as a localized or widespread patchy, reticulated, vascular network with a red-blue or violaceous hue (<a href=\"image.htm?imageKey=DERM%2F79545%7EDERM%2F61842\" class=\"graphic graphic_picture graphicRef79545 graphicRef61842 \">picture 8A-B</a>). It results from compromise of blood flow in medium sized vessels, and can occur in the setting of vasculopathy due to vasospasm, hypercoagulable states, thrombosis, increased blood viscosity, or embolic phenomena, as well as in association with vasculitis. Livedo racemosa presents with a more abrupt and broken vascular pattern than livedo reticularis (<a href=\"image.htm?imageKey=DERM%2F64023\" class=\"graphic graphic_picture graphicRef64023 \">picture 9</a>). It is strongly associated with Sneddon's syndrome, a nonvasculitic disorder characterized by livedoid skin lesions and cerebrovascular accidents, but may also occur in vasculitis and other disorders [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/13\" class=\"abstract_t\">13</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Urticaria </strong>&ndash; Unlike nonvasculitic urticaria, lesions of urticarial vasculitis usually persist for more than 24 hours, and frequently are associated with a burning sensation or pain rather than pruritus. Lesions may contain purpuric areas and can resolve with hyperpigmentation. (See <a href=\"topic.htm?path=urticarial-vasculitis\" class=\"medical medical_review\">&quot;Urticarial vasculitis&quot;</a>.)</p><p/><p>Lesions of cutaneous vasculitis most commonly occur in a symmetrical distribution on the lower legs, dependent areas, or on areas of constrictive clothing due to increased hydrostatic pressure in these sites. The skin lesions are often asymptomatic, but may be associated with pruritus, burning sensations, or pain.</p><p>The course of the disease is variable; some patients experience a single, limited episode of vasculitis, as is often the case with vasculitis secondary to medications or infection, while other vasculitides are characterized by relapsing or chronic disease [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/14\" class=\"abstract_t\">14</a>]. The duration of symptoms ranges from several days to decades [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/7\" class=\"abstract_t\">7</a>].</p><p class=\"headingAnchor\" id=\"H606119\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The presence of a petechial or purpuric eruption does not necessarily indicate the presence of vasculitis. Examples of other disorders that may present with these findings include [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/15,16\" class=\"abstract_t\">15,16</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Common vasculitis mimickers</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Pigmented purpuric dermatoses</strong> (also known as capillaritis; nonblanchable pinpoint macules, patches, or plaques, often on the lower legs) (<a href=\"image.htm?imageKey=DERM%2F67127\" class=\"graphic graphic_picture graphicRef67127 \">picture 10</a>) (see <a href=\"topic.htm?path=approach-to-the-patient-with-macular-skin-lesions#H20\" class=\"medical medical_review\">&quot;Approach to the patient with macular skin lesions&quot;, section on 'Schamberg's disease'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Macular purpura due to chronic sun exposure</strong> (<a href=\"image.htm?imageKey=DERM%2F70793\" class=\"graphic graphic_picture graphicRef70793 \">picture 11</a>)<strong>, glucocorticoid therapy, trauma, or anticoagulants </strong>(see <a href=\"topic.htm?path=approach-to-the-patient-with-macular-skin-lesions#H18\" class=\"medical medical_review\">&quot;Approach to the patient with macular skin lesions&quot;, section on 'Solar purpura (senile purpura)'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Inflammatory disorders on the lower extremities or other dependent sites</strong> (eg, stasis dermatitis or maculopapular drug eruptions) (<a href=\"image.htm?imageKey=DERM%2F72689%7EDERM%2F80847\" class=\"graphic graphic_picture graphicRef72689 graphicRef80847 \">picture 12A-B</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Arthropod bites</strong> (eg, bedbugs) (<a href=\"image.htm?imageKey=DERM%2F62345\" class=\"graphic graphic_picture graphicRef62345 \">picture 13</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Less common vasculitis mimickers</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Scurvy</strong> (perifollicular hemorrhage) (<a href=\"image.htm?imageKey=DERM%2F51219\" class=\"graphic graphic_picture graphicRef51219 \">picture 14</a>) (see <a href=\"topic.htm?path=overview-of-water-soluble-vitamins#H63\" class=\"medical medical_review\">&quot;Overview of water-soluble vitamins&quot;, section on 'Deficiency'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Platelet deficiencies or dysfunction</strong> (petechiae or macular purpura) (<a href=\"image.htm?imageKey=DERM%2F76671\" class=\"graphic graphic_picture graphicRef76671 \">picture 15</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Hypercoagulable and thrombotic disorders</strong> (noninflammatory retiform purpura) (<a href=\"image.htm?imageKey=DERM%2F65890%7EDERM%2F65011\" class=\"graphic graphic_picture graphicRef65890 graphicRef65011 \">picture 16A-B</a>) (see <a href=\"topic.htm?path=approach-to-the-patient-with-retiform-angulated-purpura\" class=\"medical medical_review\">&quot;Approach to the patient with retiform (angulated) purpura&quot;</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Cholesterol emboli</strong> (noninflammatory retiform purpura, digital gangrene, livedo reticularis) (<a href=\"image.htm?imageKey=DERM%2F69150\" class=\"graphic graphic_picture graphicRef69150 \">picture 17</a>) (see <a href=\"topic.htm?path=embolism-from-atherosclerotic-plaque-atheroembolism-cholesterol-crystal-embolism\" class=\"medical medical_review\">&quot;Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)&quot;</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Septic emboli</strong> (petechiae on the distal extremities, noninflammatory retiform purpura) (<a href=\"image.htm?imageKey=DERM%2F57118\" class=\"graphic graphic_picture graphicRef57118 \">picture 18</a>) (see <a href=\"topic.htm?path=complications-and-outcome-of-infective-endocarditis#H7\" class=\"medical medical_review\">&quot;Complications and outcome of infective endocarditis&quot;, section on 'Metastatic infection'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Systemic amyloidosis</strong> (periorbital and pinch purpura) (<a href=\"image.htm?imageKey=DERM%2F77887\" class=\"graphic graphic_picture graphicRef77887 \">picture 19</a>) (see <a href=\"topic.htm?path=pathogenesis-of-immunoglobulin-light-chain-al-amyloidosis-and-light-and-heavy-chain-deposition-diseases\" class=\"medical medical_review\">&quot;Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases&quot;</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Strongyloidiasis </strong>(periumbilical purpura) (see <a href=\"topic.htm?path=strongyloidiasis\" class=\"medical medical_review\">&quot;Strongyloidiasis&quot;</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Purpura fulminans</strong> (sharply demarcated purpuric lesions in the setting of disseminated intravascular coagulation or sepsis) (<a href=\"image.htm?imageKey=DERM%2F53920\" class=\"graphic graphic_picture graphicRef53920 \">picture 20</a>) (see <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-of-meningococcal-infection#H9\" class=\"medical medical_review\">&quot;Clinical manifestations of meningococcal infection&quot;, section on 'Purpura fulminans'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Livedoid vasculopathy</strong> (also known as atrophie blanche; presents with punched out ulcers on the lower legs with surrounding livedo reticularis or livedo racemosa) (<a href=\"image.htm?imageKey=DERM%2F52262\" class=\"graphic graphic_picture graphicRef52262 \">picture 21</a>) (see <a href=\"topic.htm?path=livedoid-vasculopathy\" class=\"medical medical_review\">&quot;Livedoid vasculopathy&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H16171984\"><span class=\"h1\">CLINICAL ASSESSMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A thorough history and complete physical examination should be performed on patients who present with cutaneous lesions suggestive of vasculitis. Doing so can offer valuable clues for diagnosis and can assist in determining the appropriate work-up for systemic involvement. Because leukocytoclastic vasculitis secondary to drug and infectious disorders accounts for many cases of cutaneous vasculitis, inquiries regarding new medications and symptoms of infection (particularly upper respiratory infections) are an important part of patient evaluation (see <a href=\"#H1117785\" class=\"local\">'Etiology'</a> above) [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2,7,17\" class=\"abstract_t\">2,7,17</a>]. Knowledge of the timing of the development of vasculitis can be helpful; drug-induced vasculitis most often occurs 7 to 10 days after the introduction of the inciting medication [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/7\" class=\"abstract_t\">7</a>].</p><p>The presence of weight loss, joint pain, sicca symptoms, oral or nasal ulcerations, hair loss, photosensitivity, Raynaud's phenomenon, or cytopenia can suggest the need to evaluate for underlying connective tissue disorders. Unexplained weight loss, fevers, chills, and night sweats may signify a malignancy. Hepatitis B and C can induce vasculitis, and symptoms and risk factors for hepatitis should be assessed. Retiform purpura in the context of recent cocaine use suggests the possibility of vasculitis due to use of levamisole-tainted cocaine. (See <a href=\"#H1117785\" class=\"local\">'Etiology'</a> above and <a href=\"#H810822\" class=\"local\">'Evaluation for vasculitis due to levamisole-contaminated cocaine'</a> below.)</p><p>In addition, patients should be questioned regarding signs or symptoms that could suggest systemic vasculitis. Examples include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fatigue, chills, night sweats</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Myalgias or arthralgias</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tea-colored urine or gross hematuria </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abdominal pain or melena</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chest pain</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dyspnea, cough, or hemoptysis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>New onset or worsening asthma</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peripheral neuropathy</p><p/><p>Clinicians should also be cognizant of symptoms that suggest the possibility of disorders that mimic vasculitis. (See <a href=\"#H606119\" class=\"local\">'Differential diagnosis'</a> above.)</p><p class=\"headingAnchor\" id=\"H16171991\"><span class=\"h1\">BIOPSY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Biopsy is an important part of the management of patients with cutaneous lesions that are suspicious for vasculitis. Lesions must be differentiated from those due to nonvasculitic disorders, and the clinical characteristics of skin lesions cannot reliably distinguish between the different types of cutaneous vasculitis. Thus, biopsies should be performed in all patients. Direct immunofluorescence (DIF) studies should also be performed in patients with cutaneous signs of small vessel vasculitis (urticarial papules and plaques and palpable purpura) to assess for immunoglobulin A (IgA) predominance, which increases the risk of renal involvement [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/18,19\" class=\"abstract_t\">18,19</a>]. (See <a href=\"#H16171998\" class=\"local\">'Direct immunofluorescence studies'</a> below.) </p><p class=\"headingAnchor\" id=\"H606549\"><span class=\"h2\">Diagnostic criteria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A histologic diagnosis of cutaneous vasculitis is confirmed by the identification of criteria that indicate an inflammatory process that results in damage to vessel walls [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2,4\" class=\"abstract_t\">2,4</a>]. Small vessels (venules and arterioles) require two out of three of the following criteria for a definitive diagnosis of vasculitis [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/7\" class=\"abstract_t\">7</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Angiocentric <span class=\"nowrap\">and/or</span> angioinvasive inflammatory infiltrates</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Disruption <span class=\"nowrap\">and/or</span> destruction of vessel walls by the inflammatory infiltrate</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fibrinoid necrosis (fibrin deposition within the vessel wall or lumen; results from the accumulation and conversion of plasma proteins [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2\" class=\"abstract_t\">2</a>])</p><p/><p>Medium-sized vessels (small arteries and veins) in the deep dermis and subcutaneous tissue require both of the following criteria to confirm vasculitis:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inflammatory infiltrate infiltrating the muscular vessel wall</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fibrinoid necrosis</p><p/><p>Other histopathologic findings that suggest but are not diagnostic for vasculitis include the presence of extravasated erythrocytes, nuclear debris (leukocytoclasia), necrosis of eccrine glands, endothelial cell damage swelling or necrosis, and cutaneous ulceration, infarction, or necrosis [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/7\" class=\"abstract_t\">7</a>]. Findings that suggest particular forms of vasculitis (eg, granulomas in granulomatosis with polyangiitis [Wegener's granulomatosis] or eosinophilic granulomatosis with polyangiitis [Churg-Strauss syndrome] and interface dermatitis in vasculitis associated with lupus erythematosus or dermatomyositis) represent additional helpful information that can be gleaned from a biopsy. </p><p>Histopathologic assessment of the biopsy specimen includes the designation of the type of inflammatory infiltrate as neutrophilic (most small and medium vessel vasculitides), lymphocytic, granulomatous, or eosinophilic [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2\" class=\"abstract_t\">2</a>]. These findings can suggest particular forms of vasculitis. For example, granulomatous inflammation may occur in granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis, and lymphocytic vasculitis can be seen in connective tissue disease-associated vasculitis. Other useful diagnostic information can be gleaned from a biopsy; the identification of interface dermatitis can support a diagnosis of vasculitis related to lupus erythematosus or dermatomyositis.</p><p class=\"headingAnchor\" id=\"H1117827\"><span class=\"h2\">Timing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The histologic characteristics of vasculitic lesions evolve quickly. Lesions that are between 24 and 48 hours old are the most likely to demonstrate diagnostic findings of vasculitis. Biopsies of leukocytoclastic vasculitis taken prior to 24 hours are likely to have some infiltration of neutrophils, but often do not yet exhibit fibrinoid necrosis. </p><p>Beyond 48 hours, the inflammatory infiltrate in leukocytoclastic vasculitis begins to shift from a neutrophilic infiltrate to lymphocytes and macrophages, and then eventually clears, leaving only evidence of fibrinoid necrosis. Because the nature of the inflammatory infiltrate is of value for diagnosis, we typically ask patients to identify a lesion that has been present for approximately 24 hours for biopsy. (See <a href=\"#H606549\" class=\"local\">'Diagnostic criteria'</a> above.)</p><p class=\"headingAnchor\" id=\"H1117834\"><span class=\"h2\">Type of biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The cutaneous features seen on clinical exam will dictate what type of biopsy should be performed. We do not perform shave biopsies, as they prevent the evaluation of vessels in the mid and deep dermis (see <a href=\"topic.htm?path=skin-biopsy-techniques#H5\" class=\"medical medical_review\">&quot;Skin biopsy techniques&quot;, section on 'Biopsy techniques'</a>). The following principles are helpful for guiding the selection of the appropriate biopsy procedure:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cutaneous findings that are suggestive of involvement of the vessels in the superficial to mid dermis (petechiae, palpable purpura, or urticarial papules or plaques) should be evaluated with a punch biopsy that is 4 mm in diameter or larger. This allows for evaluation of vessels throughout the dermis. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cutaneous findings suggestive of involvement of the vessels in the mid-dermis to the subcutaneous tissues (livedo racemosa, subcutaneous nodules, ulcers) require a large punch biopsy (8 to 10 mm) or wedge biopsy that includes the subcutaneous tissue, as the involved vessel may be located there. </p><p/><p class=\"headingAnchor\" id=\"H45090357\"><span class=\"h2\">Location</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Biopsies of petechial lesions or palpable purpura can be taken from any site within the lesion. The ideal location of the biopsy differs in patients with livedo racemosa or ulcerations. In livedo <strong>racemosa</strong>, biopsy should be performed within the pale center of an erythematous ring [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2\" class=\"abstract_t\">2</a>]. This is where the responsible vessel is likely to be located. Biopsies of livedo <strong>reticularis</strong> demonstrate nonspecific histopathologic findings, and are usually not indicated. (See <a href=\"#H606666\" class=\"local\">'Common features'</a> above.)</p><p>When ulceration is present, the biopsy should be taken from the edge of the ulcer, rather than the ulcer itself. A biopsy taken from the base of an ulcer can reveal purely incidental findings of vascular injury that resemble the histopathologic findings of vasculitis [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/7\" class=\"abstract_t\">7</a>].</p><p>Biopsies of infarcted digits are generally low yield for evaluation for vasculitis, as the infarcted area is simply a manifestation of underlying vessel obstruction. However, when cholesterol emboli or calcific vasculopathy are suspected as an inciting cause of skin lesions that resemble vasculitis, excisional biopsy can be used to evaluate for these diagnoses. (See <a href=\"topic.htm?path=embolism-from-atherosclerotic-plaque-atheroembolism-cholesterol-crystal-embolism#H5889574\" class=\"medical medical_review\">&quot;Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)&quot;, section on 'Biopsy and pathologic findings'</a> and <a href=\"topic.htm?path=approach-to-the-patient-with-retiform-angulated-purpura#H426722\" class=\"medical medical_review\">&quot;Approach to the patient with retiform (angulated) purpura&quot;, section on 'Skin biopsy'</a> and <a href=\"topic.htm?path=calciphylaxis-calcific-uremic-arteriolopathy#H9\" class=\"medical medical_review\">&quot;Calciphylaxis (calcific uremic arteriolopathy)&quot;, section on 'Diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H16171998\"><span class=\"h2\">Direct immunofluorescence studies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Direct immunofluorescence (DIF) is an essential component of the evaluation of cutaneous vasculitis in adults [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/20\" class=\"abstract_t\">20</a>] and should always be performed when available in patients with features of cutaneous small vessel vasculitis. Direct immunofluorescence utilizes labeled antibodies to identify immunoglobulin and complement deposits within the skin. </p><p class=\"headingAnchor\" id=\"H1117855\"><span class=\"h3\">Value</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>DIF is particularly important for the diagnosis of immunoglobulin A vasculitis (Henoch-Sch&ouml;nlein purpura). Renal involvement is common in this disorder, and distinguishing this diagnosis from the other small vessel vasculitides that can present with identical clinical and histopathologic features is of value. Only the identification of perivascular IgA deposition with DIF confirms the diagnosis of immunoglobulin A vasculitis (Henoch-Sch&ouml;nlein purpura) [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/21\" class=\"abstract_t\">21</a>]. (See <a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-clinical-manifestations-and-diagnosis#H13\" class=\"medical medical_review\">&quot;IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Clinical manifestations and diagnosis&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-management\" class=\"medical medical_review\">&quot;IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Management&quot;</a> and <a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-renal-manifestations\" class=\"medical medical_review\">&quot;IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Renal manifestations&quot;</a>.)</p><p>DIF is also of value for distinguishing immune-complex mediated vasculitides (such as most cases of cutaneous leukocytoclastic vasculitis, immunoglobulin A vasculitis [Henoch-Sch&ouml;nlein purpura], cryoglobulinemic vasculitis, urticarial vasculitis, and vasculitis secondary to autoimmune connective tissue disease) from pauci-immune vasculitis (granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, microscopic polyangiitis, and polyarteritis nodosa) (<a href=\"image.htm?imageKey=DERM%2F59048\" class=\"graphic graphic_table graphicRef59048 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/20\" class=\"abstract_t\">20</a>]. A negative DIF in the setting of histopathologically confirmed vasculitis should increase suspicion of these pauci-immune primary systemic vasculitides, and an appropriate work up for systemic involvement should be undertaken. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-granulomatosis-with-polyangiitis-and-microscopic-polyangiitis#H1058363559\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of granulomatosis with polyangiitis and microscopic polyangiitis&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss#H14\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)&quot;, section on 'Evaluation and diagnosis'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-polyarteritis-nodosa-in-adults#H15\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of polyarteritis nodosa in adults&quot;, section on 'Diagnosis'</a>.)</p><p>Finally, DIF can aid in the identification of the underlying etiology of the vasculitis. Predominant deposition of IgM around vessel walls suggests the possibility of vasculitis related to type 2 or type 3 cryoglobulinemia or rheumatoid vasculitis (<a href=\"image.htm?imageKey=DERM%2F59048\" class=\"graphic graphic_table graphicRef59048 \">table 1</a>). Patients with hypocomplementemic urticarial vasculitis may have deposition of IgG, complement, and fibrin on vessel walls as well as along the dermal-epidermal junction [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/7\" class=\"abstract_t\">7</a>]. (See <a href=\"topic.htm?path=overview-of-cryoglobulins-and-cryoglobulinemia#H37\" class=\"medical medical_review\">&quot;Overview of cryoglobulins and cryoglobulinemia&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-rheumatoid-vasculitis#H20\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of rheumatoid vasculitis&quot;, section on 'Diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H1117862\"><span class=\"h3\">Obtaining the specimen</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ideally, DIF is performed on a lesion that is <strong>less than 24 hours old</strong>. The inflammatory reaction stimulated by the deposition of immunoglobulins in vessel walls quickly results in the destruction of both the vessel wall and the immune complexes, resulting in negative immunofluorescence. </p><p>In contrast to the biopsies for DIF performed for the evaluation of blistering skin diseases, which are taken from perilesional skin, specimens from vasculitic lesions should be taken from within the lesions. Direct immunofluorescence studies cannot be performed on the formalin-fixed tissue obtained for hematoxylin and eosin staining, and a separate tissue specimen should be obtained.</p><p>Specimens can be placed in Michel's transport medium (a fixative) or normal saline, or can be flash-frozen with liquid nitrogen. Tissue submitted in saline must be processed within 24 hours. Examination of the specimen by a pathologist experienced in DIF microscopy is preferred.</p><p class=\"headingAnchor\" id=\"H16172005\"><span class=\"h1\">ADDITIONAL STUDIES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Because cutaneous vasculitis may be accompanied by systemic vasculitis, the possibility of systemic disease must be considered in all patients with cutaneous lesions (<a href=\"image.htm?imageKey=DERM%2F59048\" class=\"graphic graphic_table graphicRef59048 \">table 1</a>). Cutaneous small vessel vasculitis (aka cutaneous leukocytoclastic vasculitis), which is defined by vasculitis limited to the skin, is a diagnosis of exclusion.</p><p class=\"headingAnchor\" id=\"H1117877\"><span class=\"h2\">Initial studies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following studies are useful for the initial evaluation of the patient with cutaneous lesions consistent with vasculitis.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Complete blood count with differential and platelets</strong> &ndash; Cytopenias may suggest underlying connective tissue disease, leukocytosis can suggest infection or hematologic malignancy, and platelet abnormalities may reflect nonvasculitic cause of skin lesions.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Liver function tests</strong> &ndash; Evaluate for hepatic involvement.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Blood urea nitrogen <span class=\"nowrap\">(BUN)/creatinine</strong></span> &ndash; Evaluates for renal involvement and evaluates renal function.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Urinalysis with microscopy</strong> &ndash; Identifies hematuria due to renal involvement.</p><p/><p class=\"headingAnchor\" id=\"H1117885\"><span class=\"h2\">Secondary studies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If the etiology of biopsy-confirmed cutaneous vasculitis is clear (eg, a drug-induced hypersensitivity small vessel cutaneous vasculitis) then further evaluation can be delayed. When the etiology is unclear, we proceed with the following testing:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatitis B and C serologies</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum complement levels (CH50, C3, and C4) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antinuclear antibody (ANA) and anti-dsDNA, anti-Ro, anti-La, anti-RNP, and anti-Smith antibodies</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rheumatoid factor</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum cryoglobulins</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antineutrophil cytoplasmic antibodies (ANCA)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum and urine protein electrophoresis and immunofixation </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human immunodeficiency virus (HIV) antibody</p><p/><p>Positive ANCAs are helpful in the correct clinical context, but do not confirm or eliminate a diagnosis of an ANCA-associated vasculitis. Perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) are found in around 60 to 80 percent of patients with microscopic polyangiitis and approximately 50 percent of patients with eosinophilic granulomatosis with polyangiitis [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/22,23\" class=\"abstract_t\">22,23</a>]. Cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA) are positive in 90 percent of patients with granulomatosis with polyangiitis. (See <a href=\"topic.htm?path=clinical-spectrum-of-antineutrophil-cytoplasmic-autoantibodies\" class=\"medical medical_review\">&quot;Clinical spectrum of antineutrophil cytoplasmic autoantibodies&quot;</a>.)</p><p>Medications (most often <a href=\"topic.htm?path=hydralazine-drug-information\" class=\"drug drug_general\">hydralazine</a>, <a href=\"topic.htm?path=minocycline-drug-information\" class=\"drug drug_general\">minocycline</a>, and <a href=\"topic.htm?path=propylthiouracil-drug-information\" class=\"drug drug_general\">propylthiouracil</a>) may induce ANCAs (usually P-ANCA) and vasculitis that may progress to pulmonary-renal syndrome [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/24\" class=\"abstract_t\">24</a>]. Additional autoantibodies (eg, ANA, antiphospholipid antibodies, anti-double-stranded DNA antibodies, antihistone antibodies, <span class=\"nowrap\">anti-Ro/SSA,</span> <span class=\"nowrap\">anti-La/SSB)</span> and hypocomplementemia may be present in patients with drug-induced ANCA-associated vasculitis. Levamisole-contaminated cocaine use may also induce ANCA-associated vasculitis. (See <a href=\"topic.htm?path=clinical-spectrum-of-antineutrophil-cytoplasmic-autoantibodies#H13\" class=\"medical medical_review\">&quot;Clinical spectrum of antineutrophil cytoplasmic autoantibodies&quot;, section on 'Drug-induced ANCA-associated vasculitis'</a> and <a href=\"#H810822\" class=\"local\">'Evaluation for vasculitis due to levamisole-contaminated cocaine'</a> below.)</p><p>Additional laboratory tests or imaging studies are appropriate based upon patient assessment and suspicion for specific underlying disorders. As mentioned above, the cause of vasculitis is unidentifiable in some patients. (See <a href=\"#H1117785\" class=\"local\">'Etiology'</a> above and <a href=\"topic.htm?path=management-of-adults-with-idiopathic-cutaneous-small-vessel-vasculitis\" class=\"medical medical_review\">&quot;Management of adults with idiopathic cutaneous small vessel vasculitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1035433584\"><span class=\"h3\">Patients with pulmonary symptoms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We order chest radiographs in patients who present with cutaneous vasculitis and pulmonary symptoms due to the possibility of pulmonary involvement. ANCA-associated vasculitis can affect the small and medium vessels of the lung, causing inflammation and hemorrhage. Additionally, hypocomplementemic urticarial vasculitis syndrome, a subset of urticarial vasculitis, may present with hemoptysis, pleural effusion, and severe chronic obstructive pulmonary disease [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/25,26\" class=\"abstract_t\">25,26</a>].</p><p class=\"headingAnchor\" id=\"H160407114\"><span class=\"h3\">Evaluation for malignancy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An extensive search for malignancy as the cause of small vessel cutaneous vasculitis is not warranted given the rarity of this association (less than 5 percent of all patients with vasculitis [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/27-29\" class=\"abstract_t\">27-29</a>]). Patients should be up to date on age appropriate malignancy screening. Additionally, our evaluation of patients over the age of 60 who lack another identifiable cause of small vessel vasculitis includes a complete blood count with differential as well as serum and urine protein electrophoresis and immunofixation to assess for hematologic malignancies. Limiting imaging studies to those indicated based upon the presence of suggestive signs and symptoms is appropriate in this situation.</p><p class=\"headingAnchor\" id=\"H810822\"><span class=\"h3\">Evaluation for vasculitis due to levamisole-contaminated cocaine</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>ANCAs (P-ANCA or both P-ANCA and C-ANCA), antiphospholipid antibodies, and leukopenia or neutropenia are frequently detected in patients with vasculitis or vasculopathy due to levamisole-contaminated cocaine [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/8-11\" class=\"abstract_t\">8-11</a>]. (See <a href=\"#H1117785\" class=\"local\">'Etiology'</a> above and <a href=\"topic.htm?path=clinical-spectrum-of-antineutrophil-cytoplasmic-autoantibodies\" class=\"medical medical_review\">&quot;Clinical spectrum of antineutrophil cytoplasmic autoantibodies&quot;</a>.)</p><p>Urine toxicology testing can confirm cocaine use provided cocaine was utilized by the patient in the preceding two to three days. Testing for levamisole in serum or urine is commercially available, but the short half-life of levamisole (5.6 hours) makes the drug difficult to detect. In one series, levamisole was detected in only 2 out of 16 patients (13 percent) [<a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/8\" class=\"abstract_t\">8</a>]. (See <a href=\"topic.htm?path=cocaine-use-disorder-in-adults-epidemiology-pharmacology-clinical-manifestations-medical-consequences-and-diagnosis#H442013348\" class=\"medical medical_review\">&quot;Cocaine use disorder in adults: Epidemiology, pharmacology, clinical manifestations, medical consequences, and diagnosis&quot;, section on 'Drug testing'</a>.)</p><p class=\"headingAnchor\" id=\"H606945\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cutaneous vasculitis occurs as a result of inflammatory processes that target and damage small or medium-sized blood vessels in the skin (<a href=\"image.htm?imageKey=DERM%2F59048\" class=\"graphic graphic_table graphicRef59048 \">table 1</a>). A wide variety of disorders can lead to the development of cutaneous vasculitis. Infections and medications are the most common etiologies of cutaneous small vessel vasculitis. (See <a href=\"#H1117785\" class=\"local\">'Etiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The cutaneous manifestations of vasculitis include petechiae, palpable purpura, nodules, ulcers, and other findings. Clinical features of vasculitis can resemble multiple disorders and biopsy is necessary to confirm the diagnosis. Histopathologic features of vasculitis include fibrinoid necrosis and an inflammatory infiltrate invading or damaging the vessel wall. (See <a href=\"#H16171991\" class=\"local\">'Biopsy'</a> above and <a href=\"#H606549\" class=\"local\">'Diagnostic criteria'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Biopsies of lesions of cutaneous vasculitis should be taken from a lesion that is 24 to 48 hours old. Punch biopsies 4 mm in diameter are sufficient for petechial lesions, palpable purpura, or urticarial lesions. Nodules, ulcers, or livedo racemosa require large punch biopsies (8 to 10 mm) or excisional wedge biopsies. (See <a href=\"#H1117827\" class=\"local\">'Timing'</a> above and <a href=\"#H1117834\" class=\"local\">'Type of biopsy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Biopsies from most lesions of cutaneous vasculitis should be taken from within the lesion. In contrast, biopsies of livedo racemosa should be taken from within the center of an erythematous ring. Biopsies of ulcerated areas should be taken from the edge of the lesion. (See <a href=\"#H45090357\" class=\"local\">'Location'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Direct immunofluorescence (DIF) offers valuable clues for diagnosis, and a biopsy for DIF taken from lesional skin should be performed in patients with cutaneous manifestations of small vessel vasculitis. (See <a href=\"#H1117855\" class=\"local\">'Value'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Biopsy specimens for DIF should <strong>not</strong> be placed in formalin. Michel's medium is typically used to preserve the tissue for future processing. Specimens may also be placed in saline or flash-frozen with liquid nitrogen. Specimens placed in saline must be processed within 24 hours. (See <a href=\"#H1117862\" class=\"local\">'Obtaining the specimen'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Appropriate initial laboratory studies for patients with cutaneous vasculitis include a complete blood count (CBC) with differential and platelets, liver function tests, blood urea nitrogen and creatinine, and urinalysis with microscopy. Additional tests are performed if the cause of vasculitis is unclear or if systemic involvement is suspected. We perform chest radiographs in patients with pulmonary symptoms. (See <a href=\"#H16172005\" class=\"local\">'Additional studies'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/1\" class=\"nounderline abstract_t\">Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37:187.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/2\" class=\"nounderline abstract_t\">Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology 2010; 56:3.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/3\" class=\"nounderline abstract_t\">Gonzalez-Gay MA, Garcia-Porrua C, Pujol RM. Clinical approach to cutaneous vasculitis. Curr Opin Rheumatol 2005; 17:56.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/4\" class=\"nounderline abstract_t\">Jennette JC, Falk RJ. The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol 2007; 25:S52.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/5\" class=\"nounderline abstract_t\">Nagai Y, Hasegawa M, Igarashi N, et al. Cutaneous manifestations and histological features of microscopic polyangiitis. Eur J Dermatol 2009; 19:57.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/6\" class=\"nounderline abstract_t\">Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65:1.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/7\" class=\"nounderline abstract_t\">Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 2005; 27:504.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/8\" class=\"nounderline abstract_t\">Gross RL, Brucker J, Bahce-Altuntas A, et al. A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin Rheumatol 2011; 30:1385.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/9\" class=\"nounderline abstract_t\">Chung C, Tumeh PC, Birnbaum R, et al. Characteristic purpura of the ears, vasculitis, and neutropenia--a potential public health epidemic associated with levamisole-adulterated cocaine. J Am Acad Dermatol 2011; 65:722.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/10\" class=\"nounderline abstract_t\">Ullrich K, Koval R, Koval E, et al. Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol 2011; 17:193.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/11\" class=\"nounderline abstract_t\">McGrath MM, Isakova T, Rennke HG, et al. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol 2011; 6:2799.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/12\" class=\"nounderline abstract_t\">Xu LY, Esparza EM, Anadkat MJ, et al. Cutaneous manifestations of vasculitis. Semin Arthritis Rheum 2009; 38:348.</a></li><li class=\"breakAll\">Dhadly M, Dean SM, Eberhardt RT. Cutaneous changes in peripheral vascular arterial disease. In: Fitzpatrick's Dermatology in General Medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI (Eds), McGraw-Hill, 2008. Vol 2, p.1667.</li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/14\" class=\"nounderline abstract_t\">Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 2008; 9:71.</a></li><li class=\"breakAll\">Chung L, Kea B, Fiorentino DF. Cutaneous vasculitis. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo, JL, Rapini RP, et al. (Eds), Elsevier Limited, Spain 2008. Vol 1, p.347.</li><li class=\"breakAll\">Piette W. Purpura: mechanisms and differential diagnosis. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo JL, Rapini RP, et al (Eds), Elsevier Limited, Spain 2008. Vol 1, p.321.</li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/17\" class=\"nounderline abstract_t\">Loricera J, Blanco R, Ortiz-Sanju&aacute;n F, et al. Single-organ cutaneous small-vessel vasculitis according to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides: a study of 60 patients from a series of 766 cutaneous vasculitis cases. Rheumatology (Oxford) 2015; 54:77.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/18\" class=\"nounderline abstract_t\">Audemard-Verger A, Terrier B, Dechartres A, et al. Characteristics and Management of IgA Vasculitis (Henoch-Sch&ouml;nlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey. Arthritis Rheumatol 2017; 69:1862.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/19\" class=\"nounderline abstract_t\">Alalwani M, Billings SD, Gota CE. Clinical significance of immunoglobulin deposition in leukocytoclastic vasculitis: a 5-year retrospective study of 88 patients at cleveland clinic. Am J Dermatopathol 2014; 36:723.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/20\" class=\"nounderline abstract_t\">Minz RW, Chhabra S, Singh S, et al. Direct immunofluorescence of skin biopsy: perspective of an immunopathologist. Indian J Dermatol Venereol Leprol 2010; 76:150.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/21\" class=\"nounderline abstract_t\">Hung SP, Yang YH, Lin YT, et al. Clinical manifestations and outcomes of Henoch-Sch&ouml;nlein purpura: comparison between adults and children. Pediatr Neonatol 2009; 50:162.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/22\" class=\"nounderline abstract_t\">Savige J, Pollock W, Trevisin M. What do antineutrophil cytoplasmic antibodies (ANCA) tell us? Best Pract Res Clin Rheumatol 2005; 19:263.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/23\" class=\"nounderline abstract_t\">Grau RG. Churg-Strauss syndrome: 2005-2008 update. Curr Rheumatol Rep 2008; 10:453.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/24\" class=\"nounderline abstract_t\">Pendergraft WF 3rd, Niles JL. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 2014; 26:42.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/25\" class=\"nounderline abstract_t\">Grotz W, Baba HA, Becker JU, Baumg&auml;rtel MW. Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge. Dtsch Arztebl Int 2009; 106:756.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/26\" class=\"nounderline abstract_t\">Davis MD, Brewer JD. Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am 2004; 24:183.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/27\" class=\"nounderline abstract_t\">Solans-Laqu&eacute; R, Bosch-Gil JA, P&eacute;rez-Bocanegra C, et al. Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol 2008; 35:294.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/28\" class=\"nounderline abstract_t\">Fain O, Hamidou M, Cacoub P, et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 2007; 57:1473.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis/abstract/29\" class=\"nounderline abstract_t\">Bachmeyer C, Wetterwald E, Aractingi S. Cutaneous vasculitis in the course of hematologic malignancies. Dermatology 2005; 210:8.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 13769 Version 19.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H606945\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H16171969\" id=\"outline-link-H16171969\">INTRODUCTION</a></li><li><a href=\"#H1117785\" id=\"outline-link-H1117785\">ETIOLOGY</a></li><li><a href=\"#H606309\" id=\"outline-link-H606309\">TERMINOLOGY</a></li><li><a href=\"#H16171977\" id=\"outline-link-H16171977\">CUTANEOUS FINDINGS</a><ul><li><a href=\"#H606666\" id=\"outline-link-H606666\">Common features</a></li><li><a href=\"#H606119\" id=\"outline-link-H606119\">Differential diagnosis</a></li></ul></li><li><a href=\"#H16171984\" id=\"outline-link-H16171984\">CLINICAL ASSESSMENT</a></li><li><a href=\"#H16171991\" id=\"outline-link-H16171991\">BIOPSY</a><ul><li><a href=\"#H606549\" id=\"outline-link-H606549\">Diagnostic criteria</a></li><li><a href=\"#H1117827\" id=\"outline-link-H1117827\">Timing</a></li><li><a href=\"#H1117834\" id=\"outline-link-H1117834\">Type of biopsy</a></li><li><a href=\"#H45090357\" id=\"outline-link-H45090357\">Location</a></li><li><a href=\"#H16171998\" id=\"outline-link-H16171998\">Direct immunofluorescence studies</a><ul><li><a href=\"#H1117855\" id=\"outline-link-H1117855\">- Value</a></li><li><a href=\"#H1117862\" id=\"outline-link-H1117862\">- Obtaining the specimen</a></li></ul></li></ul></li><li><a href=\"#H16172005\" id=\"outline-link-H16172005\">ADDITIONAL STUDIES</a><ul><li><a href=\"#H1117877\" id=\"outline-link-H1117877\">Initial studies</a></li><li><a href=\"#H1117885\" id=\"outline-link-H1117885\">Secondary studies</a><ul><li><a href=\"#H1035433584\" id=\"outline-link-H1035433584\">- Patients with pulmonary symptoms</a></li><li><a href=\"#H160407114\" id=\"outline-link-H160407114\">- Evaluation for malignancy</a></li><li><a href=\"#H810822\" id=\"outline-link-H810822\">- Evaluation for vasculitis due to levamisole-contaminated cocaine</a></li></ul></li></ul></li><li><a href=\"#H606945\" id=\"outline-link-H606945\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/13769|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/57008\" class=\"graphic graphic_picture\">- Erythema elevatum diutinum - lower extremities</a></li><li><a href=\"image.htm?imageKey=DERM/67776\" class=\"graphic graphic_picture\">- Erythema elevatum diutinum - upper extremities</a></li><li><a href=\"image.htm?imageKey=DERM/74436\" class=\"graphic graphic_picture\">- Cocaine purpura</a></li><li><a href=\"image.htm?imageKey=DERM/77067\" class=\"graphic graphic_picture\">- Cocaine purpura on ear</a></li><li><a href=\"image.htm?imageKey=DERM/55590\" class=\"graphic graphic_picture\">- Cocaine purpura on extremity</a></li><li><a href=\"image.htm?imageKey=DERM/58626\" class=\"graphic graphic_picture\">- Cutaneous small vessel vasculitis - lower leg</a></li><li><a href=\"image.htm?imageKey=DERM/79783\" class=\"graphic graphic_picture\">- Henoch-Schonlein purpura - IgA vasculitis</a></li><li><a href=\"image.htm?imageKey=DERM/70300\" class=\"graphic graphic_picture\">- Cutaneous small vessel vasculitis - palpable purpura</a></li><li><a href=\"image.htm?imageKey=DERM/57440\" class=\"graphic graphic_picture\">- Bullous cutaneous small vessel vasculitis</a></li><li><a href=\"image.htm?imageKey=DERM/75828\" class=\"graphic graphic_picture\">- Polyarteritis nodosa</a></li><li><a href=\"image.htm?imageKey=DERM/75391\" class=\"graphic graphic_picture\">- Cutaneous polyarteritis nodosa</a></li><li><a href=\"image.htm?imageKey=DERM/58586\" class=\"graphic graphic_picture\">- Cryoglobulinemic vasculitis</a></li><li><a href=\"image.htm?imageKey=DERM/79545\" class=\"graphic graphic_picture\">- Livedo reticularis - lower extremities</a></li><li><a href=\"image.htm?imageKey=DERM/61842\" class=\"graphic graphic_picture\">- Livedo reticularis - lower leg</a></li><li><a href=\"image.htm?imageKey=DERM/64023\" class=\"graphic graphic_picture\">- Livedo racemosa in polyarteritis nodosa</a></li><li><a href=\"image.htm?imageKey=DERM/67127\" class=\"graphic graphic_picture\">- Schambergs disease</a></li><li><a href=\"image.htm?imageKey=DERM/70793\" class=\"graphic graphic_picture\">- Multiple solar purpura</a></li><li><a href=\"image.htm?imageKey=DERM/72689\" class=\"graphic graphic_picture\">- Stasis dermatitis petechiae</a></li><li><a href=\"image.htm?imageKey=DERM/80847\" class=\"graphic graphic_picture\">- Drug eruption purpura</a></li><li><a href=\"image.htm?imageKey=DERM/62345\" class=\"graphic graphic_picture\">- Bedbug bites in a group</a></li><li><a href=\"image.htm?imageKey=DERM/51219\" class=\"graphic graphic_picture\">- Scurvy - perifollicular hemorrhage</a></li><li><a href=\"image.htm?imageKey=DERM/76671\" class=\"graphic graphic_picture\">- Immune thrombocytopenia - ITP</a></li><li><a href=\"image.htm?imageKey=DERM/65890\" class=\"graphic graphic_picture\">- Antiphospholipid antibody syndrome purpura</a></li><li><a href=\"image.htm?imageKey=DERM/65011\" class=\"graphic graphic_picture\">- Antiphospholipid antibody syndrome - purpura</a></li><li><a href=\"image.htm?imageKey=DERM/69150\" class=\"graphic graphic_picture\">- Cholesterol emboli retiform purpura</a></li><li><a href=\"image.htm?imageKey=DERM/57118\" class=\"graphic graphic_picture\">- Petechiae in infective endocarditis</a></li><li><a href=\"image.htm?imageKey=DERM/77887\" class=\"graphic graphic_picture\">- Systemic AL amyloidosis purpura</a></li><li><a href=\"image.htm?imageKey=DERM/53920\" class=\"graphic graphic_picture\">- Purpura fulminans</a></li><li><a href=\"image.htm?imageKey=DERM/52262\" class=\"graphic graphic_picture\">- Livedoid vasculopathy - close view</a></li></ul></li><li><div id=\"DERM/13769|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/59048\" class=\"graphic graphic_table\">- Cutaneous vasculitis types</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-macular-skin-lesions\" class=\"medical medical_review\">Approach to the patient with macular skin lesions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-retiform-angulated-purpura\" class=\"medical medical_review\">Approach to the patient with retiform (angulated) purpura</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=calciphylaxis-calcific-uremic-arteriolopathy\" class=\"medical medical_review\">Calciphylaxis (calcific uremic arteriolopathy)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss\" class=\"medical medical_review\">Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults\" class=\"medical medical_review\">Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-granulomatosis-with-polyangiitis-and-microscopic-polyangiitis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of granulomatosis with polyangiitis and microscopic polyangiitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-polyarteritis-nodosa-in-adults\" class=\"medical medical_review\">Clinical manifestations and diagnosis of polyarteritis nodosa in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-rheumatoid-vasculitis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of rheumatoid vasculitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-meningococcal-infection\" class=\"medical medical_review\">Clinical manifestations of meningococcal infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-spectrum-of-antineutrophil-cytoplasmic-autoantibodies\" class=\"medical medical_review\">Clinical spectrum of antineutrophil cytoplasmic autoantibodies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cocaine-use-disorder-in-adults-epidemiology-pharmacology-clinical-manifestations-medical-consequences-and-diagnosis\" class=\"medical medical_review\">Cocaine use disorder in adults: Epidemiology, pharmacology, clinical manifestations, medical consequences, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=complications-and-outcome-of-infective-endocarditis\" class=\"medical medical_review\">Complications and outcome of infective endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=embolism-from-atherosclerotic-plaque-atheroembolism-cholesterol-crystal-embolism\" class=\"medical medical_review\">Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-management\" class=\"medical medical_review\">IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-renal-manifestations\" class=\"medical medical_review\">IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Renal manifestations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=livedoid-vasculopathy\" class=\"medical medical_review\">Livedoid vasculopathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-adults-with-idiopathic-cutaneous-small-vessel-vasculitis\" class=\"medical medical_review\">Management of adults with idiopathic cutaneous small vessel vasculitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-and-approach-to-the-vasculitides-in-adults\" class=\"medical medical_review\">Overview of and approach to the vasculitides in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cryoglobulins-and-cryoglobulinemia\" class=\"medical medical_review\">Overview of cryoglobulins and cryoglobulinemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cutaneous-small-vessel-vasculitis\" class=\"medical medical_review\">Overview of cutaneous small vessel vasculitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-water-soluble-vitamins\" class=\"medical medical_review\">Overview of water-soluble vitamins</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=panniculitis-recognition-and-diagnosis\" class=\"medical medical_review\">Panniculitis: Recognition and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-immunoglobulin-light-chain-al-amyloidosis-and-light-and-heavy-chain-deposition-diseases\" class=\"medical medical_review\">Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=skin-biopsy-techniques\" class=\"medical medical_review\">Skin biopsy techniques</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=strongyloidiasis\" class=\"medical medical_review\">Strongyloidiasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=urticarial-vasculitis\" class=\"medical medical_review\">Urticarial vasculitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vasculitis-in-children-evaluation\" class=\"medical medical_review\">Vasculitis in children: Evaluation</a></li></ul></div></div>","javascript":null}